×

Methods and formulations of cremophor-free taxanes

  • US 6,506,405 B1
  • Filed: 08/01/2000
  • Issued: 01/14/2003
  • Est. Priority Date: 02/22/1993
  • Status: Expired due to Fees
First Claim
Patent Images

1. A pharmaceutically acceptable formulation of paclitaxel for treatment of primary tumors in a subject which achieves high local concentration of said paclitaxel at the tumor site, said formulation being substantially free of cremophor and comprising paclitaxel in a dose in the range of about 30 mg/m2 to about 1000 mg/m2.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×